Drug Discovery World

OCTOBER 26, 2023

While we are using standard commercially available processes for genomics, we have invested massively into high-throughput and high-resolution transcriptomics, proteomics, and metabolomics methods. PanHunter is a web-based solution that was launched as a Software-as-a-Service (SaaS) product in 2022.

Drugs 52

Drugs Protein Genome Genomics 52

pharmaphorum

JANUARY 19, 2022

This will provide researchers with the option to analyse their data without the need to learn code, which can be a challenging requirement for those not au fait with bioinformatics. Research Instruments is the main distributor for genomic and life science research products in the region.

RNA 71

RNA Research Life Science Bioinformatics 71

pharmaphorum

APRIL 7, 2022

During the initial stage of the collaboration, Ares developed a an AI-powered anti-infectives platform using microbiological lab techniques and bioinformatics that can be used to identify effective antimicrobial compounds or combinations against specific pathogens, which Sandoz can use to inform its “portfolio and commercial decisions.”

Bioinformatics 52

Bioinformatics Genetics Genome Genomics 52

Drug Discovery World

JULY 11, 2023

Now, with the growth of publicly available genomics, transcriptomics, and proteomics databases, the ability to quickly carry out large-scale DNA, RNA, and protein screenings, and the availability of massive sets of de-identified patient data, the amount of high-value, analysable data has reached enormous proportions. Industry 4.0’

Big Data 40

Big Data Development Life Science Drugs 40

Scienmag

MAY 7, 2021

The study […].

Genome 52

Genome Genomics Bioinformatics Production 52

The Pharma Data

SEPTEMBER 11, 2021

This precise and rational approach to library fabrication combined with sophisticated bioinformatics and software expertise expedites antibody discovery by decreasing risk, increasing speed, and lowering the failure rate for antibody therapeutic development. About Twist Bioscience Corporation.

Antibody 52

Antibody DNA Containment Manufacturing 52

Drug Discovery World

JULY 26, 2023

With 100-fold the number of genes in the human genome 1 , this microbial collection is a rich genetic signature of clinical significance that we have only recently gained the tools to explore. Collectively, these systems biology bioinformatic puzzles often require partnerships to solve.

Medicine 52

Medicine Genome Genomics Bioinformatics 52

Roots Analysis

AUGUST 28, 2022

The up-and-coming field of spatial genomics in biology promises to bridge the gap between high plex, high throughput, and high resolution. 70+ spatial Genomics solutions are developed by industry and non-industry players. 70+ spatial Genomics solutions are developed by industry and non-industry players. Concluding Remarks.

Genome 52

Genome Genomics RNA Genome Project 52

XTalks

MAY 20, 2022

They also assist in the testing of medical devices and development of drug products. There are different fields to explore as a clinical scientist — these include clinical bioinformatics, physiological sciences, pathology, medical physics and more. Their work might involve matching blood samples for transfusions. Radiotherapy Physics.

Scientist 105

Scientist Life Science Clinical Research Doctors 105

The Pharma Data

DECEMBER 16, 2020

” ABOUT PANOMICS/PANHUNTER PanOmics involves the innovative use of genomics, transcriptomics, proteomics, and phenotypic data in an integrated fashion. On this basis, Evotec has built a broad and deep pipeline of more than 100 co-owned product opportunities at clinical, pre-clinical and discovery stages (EVT Innovate).

Protein 40

Protein Containment Bioinformatics Drugs 40

XTalks

DECEMBER 13, 2023

Modern is making significant strides in advancing its mRNA technology and diversifying its product portfolio to address a broad spectrum of medical conditions. Dynavax boasts two successful commercial products in its portfolio. Notably, R&D expenditures for the second quarter of 2023 surged by 62 percent to reach $1.1

Genetics 111

Genetics Vaccination Vaccine DNA 111

The Pharma Data

JANUARY 21, 2021

Founded and led for 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to eight FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. For a list of this year’s finalists, visit [link].

Scientist 40

Scientist Engineer Medicine Bioinformatics 40

Drug Discovery World

NOVEMBER 8, 2023

Marketing Product Manager, Product, NanoTemper Technologies. The luncheon presentation will be done by James Keck, PhD, President’s Innovation Fellow and Senior Director, Innovation and Product Development, Product Development, The Jackson Laboratory. The presentations which follow include: Peter Tessier, PhD, Albert M.

Antibody 64

Antibody Engineer Protein Scientist 64

Drug Discovery World

NOVEMBER 15, 2022

“We facilitate parallel DNA synthesis by coupling our chip technology with our re-engineered chemical method that can thermally control DNA synthesis at every single action site on the microchip,” says Dr Michael Daniels, Head of Product Management at Evonetix. .

DNA 98

DNA Drugs Antibody Engineer 98

Drug Discovery World

OCTOBER 17, 2022

By Dr Christof Gänzler, Product Marketing Biology at PerkinElmer Informatics. . The end game: reducing late-stage candidate failure and driving stronger innovation, productivity, and throughput. It’s a centuries-old truism: the fastest runner doesn’t always win the race. It takes more than speed to advance and maintain performance.

Marketing 52

Marketing Scientist Gene Expression Drugs 52

The Pharma Data

JANUARY 10, 2021

I actually think neuroscience is going to heat up in 2021,” said Ben Zeskind , co-founder and CEO of Immuneering , which is using bioinformatics and computational biology to develop new drugs in this space, along with oncology and immuno-oncology. Moving on From the Amyloid Hypothesis. “I And then, always, ‘science matters.’

Vaccination 52

Vaccination Vaccine Regulation Drugs 52